Case Report

Isolated Splenic Metastasi from Primary Lung Adenocarcinoma

Authors: Brian J. Schmidt, MD, Stephen L. Smith, MD

Abstract

Metastatic disease involving the spleen is uncommon, and isolated metastasis to the spleen is extremely rare. Most patients with splenic metastases have widely disseminated metastatic disease. A current literature review shows the incidence of isolated splenic metastasis ranges from 0 to 26% of all patients with splenic metastases. The reported primary malignancies of patients with splenic metastases include lung, colorectal, endometrial, ovarian, thyroid, pancreatic, gastric cancers, and, most commonly, melanoma. Although most patients with splenic metastases are clinically asymptomatic for splenic lesions, there have been reports of painful splenomegaly, splenic vein thrombosis, and splenic rupture, making diagnosis and consideration of prompt therapeutic intervention important. The time from diagnosis of a primary lung tumor to the discovery of splenic metastases ranges from 0 to 8 years in the literature. We report a rare case of an asymptomatic, isolated splenic metastasis in a 72-year-old man diagnosed 25 months after resection of an adenocarcinoma of the lung.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Edelman A, Rotterdam H. Solitary splenic metastasis of an adenocarcinoma of the lung. Am J Clin Pathol 1990; 94: 326–328.
 
2. Kinoshita A, Nakano M, Fukuda M, et al. Splenic metastasis from lung cancer. Neth J Med 1995; 47: 219–223.
 
3. Klein B, Stein M, Kuten A, et al. Splenomegaly and solitary spleen metastasis in solid tumors. Cancer 1987; 60: 100–102.
 
4. Lam K, Tang V. Metastatic tumors to the spleen: A 25-year clinicopathologic study. Arch Pathol Lab Med 2000; 124: 526–530.
 
5. Lee S, Morgenstern L, Phillips E, et al. Splenectomy for splenic metastases: A changing clinical spectrum. Am Surg 2000; 66: 837–840.
 
6. Macheers S, Mansour K. Management of isolated splenic metastases from carcinoma of the lung: A case report and review of the literature. Am Surg 1992; 58: 683–685.
 
7. Massarweh S, Dhingra H. Solitary splenic metastasis in lung cancer with spontaneous rupture. J Clin Oncol 2001; 19: 1574–1575.
 
8. Takada T, Takami H. Solitary splenic metastasis of a carcinoid tumor of the lung 8 years postoperatively. J Surg Oncol 1998; 67: 47–48.
 
9. Berge T. Splenic metastases, frequencies, and patterns. Acta Pathol Microbiol Scand 1974; 82: 499–506.
 
10. Sabiston DC. Textbook of Surgery. Philadelphia, PA, W. B. Saunders Co., 1997, 15th ed, pp 1187–1214, 1865–1876.
 
11. Gupta P, Harvey L. Spontaneous rupture of the spleen secondary to metastatic carcinoma. Br J Surg 1993; 80: 613.
 
12. Nash D, Sampson C. Secondary carcinoma of the spleen, its incidence in 544 cases, and a review of the literature. J Natl Med Assoc 1966; 58: 442–446.
 
13. Rydell W, Ellis R. Spontaneous rupture of the spleen from metastatic carcinoma. JAMA 1978; 240: 53–54.
 
14. Morgenstern L, Rosenberg J, Geller S. Tumors of the spleen. World J Surg 1985; 9: 468–476.